| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,477 |
6,950 |
$527K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,502 |
2,433 |
$220K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,620 |
1,602 |
$141K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,988 |
2,896 |
$101K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
351 |
349 |
$38K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,403 |
2,191 |
$33K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,369 |
3,292 |
$30K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
217 |
209 |
$5K |
| 99215 |
Prolong outpt/office vis |
32 |
32 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
30 |
29 |
$2K |
| S9083 |
Global fee urgent care centers |
13 |
12 |
$981.00 |
| 81003 |
|
578 |
564 |
$906.47 |
| 81025 |
|
115 |
112 |
$849.08 |
| 87807 |
|
51 |
49 |
$512.72 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
54 |
53 |
$31.71 |